Target type: biologicalprocess
The multiplication or reproduction of cells, resulting in the expansion of a cell population in the midbrain. [GO_REF:0000021, GOC:dgf]
Cell proliferation in the midbrain is a complex and tightly regulated process that is essential for the development and maintenance of this crucial brain region. The midbrain, located between the forebrain and hindbrain, houses structures vital for motor control, sensory processing, and reward systems.
During embryonic development, the midbrain undergoes a rapid period of cell division and differentiation, generating a diverse population of neurons and glial cells. This process involves several key steps:
1. **Cell cycle regulation:** The midbrain progenitor cells, which give rise to all midbrain neurons and glia, enter a cycle of cell division. The cell cycle is regulated by a complex network of proteins, including cyclins, cyclin-dependent kinases (CDKs), and cyclin-dependent kinase inhibitors (CDKIs). These proteins control the progression of the cell cycle through different stages: G1 (gap 1), S (DNA synthesis), G2 (gap 2), and M (mitosis).
2. **Proliferation and differentiation:** Progenitor cells proliferate extensively in the midbrain, producing a large pool of cells. These cells then differentiate into various cell types, including dopaminergic neurons, GABAergic neurons, and glial cells. The process of differentiation is influenced by a combination of intrinsic and extrinsic factors, such as transcription factors, signaling molecules, and the surrounding microenvironment.
3. **Neurogenesis and gliogenesis:** The generation of neurons (neurogenesis) and glial cells (gliogenesis) occurs within specific regions of the midbrain, such as the ventral midbrain, where dopaminergic neurons are produced. Neurogenesis involves the expression of specific genes that control the development of neuronal characteristics, while gliogenesis involves the expression of genes that regulate the formation of glial cell types.
4. **Cell migration and axon guidance:** Once generated, neurons and glial cells migrate to their final destinations within the midbrain. This migration process is guided by chemoattractants and chemorepellents, which act as molecular cues to direct cells along specific pathways. Axons, the long projections of neurons, also extend from the cell body and navigate through the developing brain to connect with their targets.
In the adult midbrain, cell proliferation persists at a lower rate, contributing to the maintenance and repair of existing brain structures. This process, known as adult neurogenesis, occurs in specific niches within the midbrain, such as the subventricular zone (SVZ) and the dentate gyrus of the hippocampus. Adult neurogenesis is thought to play a role in learning and memory, as well as in the recovery from brain injury.
Several signaling pathways, including the Wnt, Shh, and BMP pathways, play crucial roles in regulating cell proliferation in the midbrain. These pathways are activated by specific ligands and involve a cascade of intracellular events that ultimately influence the expression of genes involved in cell cycle control and differentiation.
Disruptions in cell proliferation in the midbrain can have severe consequences, leading to neurodevelopmental disorders, such as Parkinson's disease, which is characterized by the loss of dopaminergic neurons in the substantia nigra. Understanding the intricate mechanisms of cell proliferation in the midbrain is critical for developing therapeutic strategies for these disorders.'
"
Protein | Definition | Taxonomy |
---|---|---|
Protein Wnt-3a | A protein Wnt-3a that is encoded in the genome of human. [PRO:DNx, UniProtKB:P56704] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
CCT251545 | CCT251545 : A chloropyridine that is 3-chloropyridine substituted by a 1-oxo-2,8-diazaspiro[4.5]decan-8-yl group and a 4-(1-methyl-1H-pyrazol-4-yl)phenyl group at positions 4 and 5, respectively. It is an orally bioavailable inhibitor of Wnt signaling (IC50 = 5 nM) and a potent and selective chemical probe for cyclin-dependent kinases CDK8 and CDK19. CCT251545: a Wnt signaling inhibitor; structure in first source | azaspiro compound; chloropyridine; pyrazoles | antineoplastic agent; EC 2.7.11.22 (cyclin-dependent kinase) inhibitor; Wnt signalling inhibitor |
xav939 | XAV939 : A thiopyranopyrimidine in which a 7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidine skeleton is substituted at C-4 by a hydroxy group and at C-2 by a para-(trifluoromethyl)phenyl group. XAV939: selectively inhibits beta-catenin-mediated transcription; structure in first source | (trifluoromethyl)benzenes; thiopyranopyrimidine | tankyrase inhibitor |
nvp-tnks656 |